[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:t-cell-chimerism":3},{"name":4,"total":5,"recruiting":5,"trials":6},"T cell chimerism",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT04024761","A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation",[11],"Phase 1","RECRUITING","2026-08-26T02:18:54.586325Z","2026-05-05T02:43:29.028485Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT02203903","Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies",[11],"2026-08-26T02:17:49.709549Z","2026-05-05T02:43:27.423311Z"]